A citation-based method for searching scientific literature

Giuseppe G Loscocco, Giacomo Coltro, Paola Guglielmelli, Alessandro M Vannucchi. Cells 2021
Times Cited: 3







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
100


Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.
H Gisslinger, G Jeryczynski, B Gisslinger, A Wölfler, S Burgstaller, V Buxhofer-Ausch, M Schalling, M-T Krauth, A-I Schiefer, C Kornauth,[...]. Leukemia 2016
35
66

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
66

Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Paul Deschamps, Mufaddal Moonim, Deepti Radia, Natalia Curto-Garcia, Claire Woodley, Sarah Bassiony, Jennifer O'Sullivan, Patrick Harrington, Kavita Raj, Yvonne Francis,[...]. Br J Haematol 2021
5
66


The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi. Blood Cancer J 2018
254
66

Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Laura Palomo, Manja Meggendorfer, Stephan Hutter, Sven Twardziok, Vera Ademà, Irene Fuhrmann, Francisco Fuster-Tormo, Blanca Xicoy, Lurdes Zamora, Pamela Acha,[...]. Blood 2020
51
66

Myeloid neoplasms with eosinophilia.
Andreas Reiter, Jason Gotlib. Blood 2017
129
66


Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis.
Alessandra Carobbio, Alberto Ferrari, Arianna Masciulli, Arianna Ghirardi, Giovanni Barosi, Tiziano Barbui. Blood Adv 2019
65
66

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.
Leonardo Boiocchi, Rosanny Espinal-Witter, Julia Turbiner Geyer, Julia Steinhilber, Irina Bonzheim, Daniel M Knowles, Falko Fend, Attilio Orazi. Mod Pathol 2013
53
66

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups.
Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, Domenico Penna, Rangit R Vallapureddy, Terra L Lasho, Christy Finke, Kebede H Begna, Michelle A Elliott, C Christopher Hook,[...]. Mayo Clin Proc 2019
57
66

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
Paola Guglielmelli, Giuseppe G Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie,[...]. Blood Cancer J 2021
11
66

Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Michael Szardenings, Hye-Ran Kim, Myung-Geun Shin. Oncotarget 2016
17
33

Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg,[...]. N Engl J Med 2011
33


The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations.
Umberto Gianelli, Daniele Cattaneo, Anna Bossi, Ivan Cortinovis, Leonardo Boiocchi, Yen-Chun Liu, Claudia Augello, Arturo Bonometti, Stefano Fiori, Nicola Orofino,[...]. Mod Pathol 2017
4
33

The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
N Maslah, B Cassinat, E Verger, J-J Kiladjian, L Velazquez. Leukemia 2017
62
33

Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Natasha Szuber, Ayalew Tefferi. Blood Cancer J 2018
14
33

Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding.
Alicia Veninga, Ilaria De Simone, Johan W M Heemskerk, Hugo Ten Cate, Paola E J van der Meijden. Haematologica 2020
22
33


Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
33

Chronic myeloproliferative disorders in bone marrow biopsies.
A Georgii, K F Vykoupil, T Buhr, H Choritz, U Döhler, V Kaloutsi, M Werner. Pathol Res Pract 1990
133
33

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
Alessandra Iurlo, Umberto Gianelli, Daniele Cattaneo, Juergen Thiele, Attilio Orazi. Am J Hematol 2017
18
33

Polycythemia Vera in a Patient With Heterozygous Beta-Thalassemia: Coincidence or Causal Relationship?
Konstantinos Kottas, Anastasios Marathonitis, Aikaterini Nodarou, Georgios Kanellis, Konstantinos Christopoulos. Cureus 2020
1
100

Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
Florian Zink, Simon N Stacey, Gudmundur L Norddahl, Michael L Frigge, Olafur T Magnusson, Ingileif Jonsdottir, Thorgeir E Thorgeirsson, Asgeir Sigurdsson, Sigurjon A Gudjonsson, Julius Gudmundsson,[...]. Blood 2017
393
33

Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding.
Abhishek A Mangaonkar, Aaron J Tande, Delamo I Bekele. Curr Hematol Malig Rep 2021
7
33


Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study.
Daniele Cattaneo, Giorgio Alberto Croci, Cristina Bucelli, Silvia Tabano, Marta Giulia Cannone, Gabriella Gaudioso, Maria Chiara Barbanti, Kordelia Barbullushi, Paola Bianchi, Elisa Fermo,[...]. Front Oncol 2021
4
33

Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Umberto Gianelli, Alessandra Iurlo, Daniele Cattaneo, Anna Bossi, Ivan Cortinovis, Claudia Augello, Alessia Moro, Federica Savi, Roberto Castelli, Cecilia Brambilla,[...]. Leuk Res 2015
11
33

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.
Hans Michael Kvasnicka, Attilio Orazi, Juergen Thiele, Giovanni Barosi, Carlos E Bueso-Ramos, Alessandro M Vannucchi, Robert P Hasserjian, Jean-Jacques Kiladjian, Umberto Gianelli, Richard Silver,[...]. Am J Hematol 2017
25
33

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
33

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, Barbara Mora, Emmanuelle Verger, Nabih Maslah, Aurelie Plessier, Pierre-Emmanuel Rautou, Isabelle Ollivier-Hourman, Victor De Ledinghen,[...]. Blood Adv 2020
12
33

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.
Anna L Brown, Peer Arts, Catherine L Carmichael, Milena Babic, Julia Dobbins, Chan-Eng Chong, Andreas W Schreiber, Jinghua Feng, Kerry Phillips, Paul P S Wang,[...]. Blood Adv 2020
46
33

Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
Ada Maria Florena, Claudio Tripodo, Emilio Iannitto, Rossana Porcasi, Sabrina Ingrao, Vito Franco. Haematologica 2004
66
33


DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.
Manuel Buscarlet, Sylvie Provost, Yassamin Feroz Zada, Amina Barhdadi, Vincent Bourgoin, Guylaine Lépine, Luigina Mollica, Natasha Szuber, Marie-Pierre Dubé, Lambert Busque. Blood 2017
201
33

Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.
Andrew L Young, Grant A Challen, Brenda M Birmann, Todd E Druley. Nat Commun 2016
371
33

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.
Jürgen Thiele, Attilio Orazi, Hans Michael Kvasnicka, Vito Franco, Emanuela Boveri, Umberto Gianelli, Heinz Gisslinger, Francesco Passamonti, Ayalew Tefferi, Tiziano Barbui. Haematologica 2012
12
33

The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis.
Yuh Cai Chia, Md Asiful Islam, Phil Hider, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan, Marini Ramli. Cancers (Basel) 2021
7
33

Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
Umberto Gianelli, Anna Bossi, Ivan Cortinovis, Elena Sabattini, Claudio Tripodo, Emanuela Boveri, Alessia Moro, Riccardo Valli, Maurilio Ponzoni, Ada M Florena,[...]. Mod Pathol 2014
30
33

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
B J Longley, L Tyrrell, S Z Lu, Y S Ma, K Langley, T G Ding, T Duffy, P Jacobs, L H Tang, I Modlin. Nat Genet 1996
505
33

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
N L Harris, E S Jaffe, H Stein, P M Banks, J K Chan, M L Cleary, G Delsol, C De Wolf-Peeters, B Falini, K C Gatter. Blood 1994
33



Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.
Alberto Quattrocchi, Carlo Maiorca, Monia Billi, Simona Tomassini, Elisabetta De Marinis, Natalia Cenfra, Francesco Equitani, Martina Gentile, Alessia Ceccherelli, Cristina Banella,[...]. Am J Hematol 2020
4
33

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.
Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Paola Guglielmelli, Alessandro Rambaldi, Alessandro M Vannucchi, Ayalew Tefferi. Am J Hematol 2014
51
33




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.